Ruella, M., Barrett, D. M., Kenderian, S. S., Shestova, O., Hofmann, T. J., Perazzelli, J., . . . Gill, S. (2016). Dual CD19 and CD123 targeting prevents antigen-loss relapses after CD19-directed immunotherapies. J Clin Invest.
Stile di citazione ChicagoRuella, Marco, et al. "Dual CD19 and CD123 Targeting Prevents Antigen-loss Relapses After CD19-directed Immunotherapies." J Clin Invest 2016.
Citazione MLARuella, Marco, et al. "Dual CD19 and CD123 Targeting Prevents Antigen-loss Relapses After CD19-directed Immunotherapies." J Clin Invest 2016.
Attenzione: Queste citazioni potrebbero non essere precise al 100%.